316
Views
25
CrossRef citations to date
0
Altmetric
Original Articles

Hypolipidemic Effect of Young Persimmon Fruit in C57BL/6.KOR-ApoEshl Mice

, &
Pages 2651-2659 | Received 07 May 2008, Accepted 19 Jun 2008, Published online: 22 May 2014

  • 1) NIH publication, Third report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults. National cholesterol education program, no. 01-3670 (2001).
  • 2) Ferdinand, K. C., The importance of aggressive lipid management in patients at risk: evidence from recent clinical trials. Clin. Cardiol., 27, 12–15 (2004).
  • 3) Bittner, V., Perspectives on dyslipidemia and coronary heart disease in women. J. Am. Coll. Cardiol., 46, 1628–1635 (2005).
  • 4) Illingworth, D. R., and Bacon, S., Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia. Am. J. Cardiol., 60, 33G–42G (1987).
  • 5) Kramer, W., and Glombik, H., Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs. Curr. Med. Chem., 13, 997–1016 (2006).
  • 6) Auger, C., Teissedre, P. L., Gérain, P., Lequeux, N., Bornet, A., Serisier, S., Besançon, P., Caporiccio, B., Cristol, J. P., and Rouanet, J. M., Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. J. Agric. Food Chem., 53, 2015–2021 (2005).
  • 7) Torres, N., Torre-Villalvazo, I., and Tovar, A. R., Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. J. Nutr. Biochem., 17, 365–373 (2006).
  • 8) Matsumoto, K., Watanabe, Y., and Yokoyama, S., Okara, soybean residue, prevents obesity in a diet-induced murine obesity model. Biosci. Biotechnol. Biochem., 71, 720–727 (2007).
  • 9) Martins, J. M., Riottot, M., de Abreu, M. C., Viegas-Crespo, A. M., Lança, M. J., Almeida, J. A., Freire, J. B., and Bento, O. P., Cholesterol-lowering effects of dietary blue lupin (Lupinus angustifolius L.) in intact and ileorectal anastomosed pigs. J. Lipid Res., 46, 1539–1547 (2005).
  • 10) Matsushima, Y., Hayashi, S., and Tachibana, M., Spontaneously hyperlipidemic (SHL) mice: Japanese wild mice with apolipoprotein E deficiency. Mamm. Genome, 10, 352–357 (1999).
  • 11) Meir, K. S., and Leitersdorf, E., Atherosclerosis in the apolipoprotein E-deficient mouse: a decade of progress. Arterioscler. Thromb. Vasc. Biol., 24, 1006–1014 (2004).
  • 12) Matsushima, Y., Sakurai, T., Ohoka, A., Ohnuki, T., Tada, N., Asoh, Y., and Tachibana, M., Four strains of spontaneously hyperlipidemic (SHL) mice: phenotypic distinctions determined by genetic backgrounds. J. Atheroscler. Thromb., 8, 71–79 (2001).
  • 13) Gorinstein, S., Bartnikowska, E., Kulasek, G., Zemser, M., and Trakhtenberg, S., Dietary persimmon improves lipid metabolism in rats fed diets containing cholesterol. J. Nutr., 128, 2023–2027 (1998).
  • 14) Lee, J. S., Lee, M. K., Ha, T. Y., Bok, S. H., Park, H. M., Jeong, K. S., Woo, M. N., Do, G. M., Yeo, J. Y., and Choi, M. S., Supplementation of whole persimmon leaf improves lipid profiles and suppresses body weight gain in rats fed high-fat diet. Food Chem. Toxicol., 44, 1875–1883 (2006).
  • 15) Matsumoto, K., Watanabe, Y., Ohya, M. A., and Yokoyama, S., Young persimmon fruits prevent the rise in plasma lipids in a diet-induced murine obesity model. Biol. Pharm. Bull., 29, 2532–2535 (2006).
  • 16) Bligh, E. G., and Dyer, W. J., A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol., 37, 911–917 (1959).
  • 17) Usui, S., Hara, Y., Hosaki, S., and Okazaki, M., A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J. Lipid Res., 43, 805–814 (2002).
  • 18) Matsumoto, K., Hiraiwa, N., Yoshiki, A., Ohnishi, M., and Kusakabe, M., PDGF receptor-alpha deficiency in glomerular mesangial cells of tenascin-C knockout mice. Biochem. Biophys. Res. Commun., 290, 1220–1227 (2002).
  • 19) den Boer, M., Voshol, P. J., Kuipers, F., Havekes, L. M., and Romijn, J. A., Hepatic steatosis: a mediator of the metabolic syndrome: lessons from animal models. Arterioscler. Thromb. Vasc. Biol., 24, 644–649 (2004).
  • 20) Davis, R. A., Miyake, J. H., Hui, T. Y., and Spann, N. J., Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP. J. Lipid Res., 43, 533–543 (2002).
  • 21) Kobayashi, M., Ikegami, H., Fujisawa, T., Nojima, K., Kawabata, Y., Noso, S., Babaya, N., Itoi-Babaya, M., Yamaji, K., Hiromine, Y., Shibata, M., and Ogihara, T., Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin. Diabetes, 56, 239–247 (2007).
  • 22) Root, C., Smith, C. D., Sundseth, S. S., Pink, H. M., Wilson, J. G., and Lewis, M. C., Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94. J. Lipid Res., 43, 1320–1330 (2002).
  • 23) Houten, S. M., Watanabe, M., and Auwerx, J., New EMBO member’s review endocrine functions of bile acids. EMBO J., 25, 1419–1425 (2006).
  • 24) Horton, J. D., Shimomura, I., Brown, M. S., Hammer, R. E., Goldstein, J. L., and Shimano, H., Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J. Clin. Invest., 101, 2331–2339 (1998).
  • 25) Amemiya-Kudo, M., Shimano, H., Hasty, A. H., Yahagi, N., Yoshikawa, T., Matsuzaka, T., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., Osuga, J., Harada, K., Gotoda, T., Sato, R., Kimura, S., Ishibashi, S., and Yamada, N., Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J. Lipid Res., 43, 1220–1235 (2002).
  • 26) Gälman, C., Ostlund-Lindqvist, A. M., Björquist, A., Schreyer, S., Svensson, L., Angelin, B., and Rudling, M., Pharmacological interference with intestinal bile acid transport reduces plasma cholesterol in LDL receptor/apoE deficiency. FASEB J., 17, 265–267 (2003).
  • 27) Zelcer, N., and Tontonoz, P., Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest., 116, 607–613 (2006).
  • 28) Miao, B., Zondlo, S., Gibbs, S., Cromley, D., Hosagrahara, V. P., Kirchgessner, T. G., Billheimer, J., and Mukherjee, R., Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J. Lipid Res., 45, 1410–1417 (2004).
  • 29) Postic, C., and Girard, J., Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest., 118, 829–838 (2008).
  • 30) Grefhorst, A., Elzinga, B. M., Voshol, P. J., Plösch, T., Kok, T., Bloks, V. W., van der Sluijs, F. H., Havekes, L. M., Romijn, J. A., Verkade, H. J., and Kuipers, F., Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J. Biol. Chem., 277, 34182–34190 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.